Toulouse, France

Michel Major


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2000-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Michel Major

Introduction

Michel Major is an accomplished inventor based in Toulouse, France, known for his innovative contributions to the field of biotechnology. His work is particularly focused on developing novel methods and formulations for pharmaceutical and cosmetic applications, showcasing his commitment to advancing scientific knowledge and improving health outcomes.

Latest Patents

Michel Major holds three patents, the latest of which include:

1. **Synthetic Particulate Vectors and Preparation Process** - This invention comprises a synthetic particulate vector with a non-liquid hydrophilic nucleus and no external lipid layer. The method described encapsulates an ionizable active principle within these vectors, which can be utilized in pharmaceutical, cosmetological, or food compositions.

2. **Mucosal Administration of Substances to Mammals** - This novel method provides an effective way to administer substances to mammals via mucosal surfaces, using a Biovector that incorporates a core made from natural polymers. This Biovector enhances the absorption of the substance, potentially increasing its efficacy.

Career Highlights

Michel Major is affiliated with Biovector Therapeutics, S.A., where he continues to make significant strides in biotechnology. His extensive research and development efforts aim to optimize the delivery systems of therapeutic agents, thereby enhancing treatment outcomes.

Collaborations

Throughout his career, Michel Major has collaborated with notable peers such as Didier Betbeder and Roger Kravtzoff. Together, they contribute to advancing the field of biotechnology through innovative research and development initiatives.

Conclusion

Michel Major's inventive spirit and dedication to improving biotechnological solutions have positioned him as a prominent figure in his field. With his latest patents and ongoing work at Biovector Therapeutics, he continues to pave the way for future advancements in the health sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…